Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 10:01 am Purchase | 2021-12-31 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Avoro Capital Advisors LLC | 3,235,000 8.800% | 2,858 (+0.09%) | Filing History |
| 2022-02-11 10:01 am Purchase | 2021-12-31 | 13G | MIRATI THERAPEUTICS INC MRTX | Avoro Capital Advisors LLC | 5,075,000 9.200% | 540,000 (+11.91%) | Filing History |
| 2022-02-11 10:00 am Purchase | 2021-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | Avoro Capital Advisors LLC | 4,985,000 9.700% | 2,185,000 (+78.04%) | Filing History |
| 2021-11-24 3:48 pm Sale | 2021-11-22 | 13D | ACCELERON PHARMA INC XLRN | Avoro Capital Advisors LLC | 0 0.000% | -4,476,100 (Position Closed) | Filing History |
| 2021-10-05 12:30 pm Purchase | 2021-09-30 | 13D | ACCELERON PHARMA INC XLRN | Avoro Capital Advisors LLC | 4,476,100 7.300% | 4,476,100 (New Position) | Filing History |
| 2021-08-30 5:27 pm Purchase | 2021-08-26 | 13D | WHITEHAWK THERAPEUTICS, INC. C WHWK | Avoro Capital Advisors LLC | 2,211,752 10.700% | 1,911,752 (+637.25%) | Filing History |